Bone marrow involvement in Burkitt's lymphoma. 1977

R D Brunning, and R W McKenna, and C D Bloomfield, and P Coccia, and K J Gajl-Peczalska

Thirteen patients with a malignant lymphoma exhibiting the cytologic characteristics of Burkitt's lymphoma manifested marrow involvement at the time of initial diagnosis (11 patients) or later in the course of the disease (two patients). Eleven patients were 16 years of age or younger. Eight had evidence of abdominal disease, five in the ileocecal area. Despite extensive marrow involvement in most of these patients, frankly leukemic blood pictures were uncommon. Platelet counts and absolute neutrophil counts were frequently normal. Membrane surface markers were studied in four patients. The malignant cells from three exhibited mulambda surface immunoglobulin; the cells from the other manifested muk surface immunoglobulin. All of the patients had a rapid clinical course in spite of intensive chemotherapy. The median survival from detection of marrow involvement was 2.5 months.

UI MeSH Term Description Entries
D007136 Immunoglobulins Multi-subunit proteins which function in IMMUNITY. They are produced by B LYMPHOCYTES from the IMMUNOGLOBULIN GENES. They are comprised of two heavy (IMMUNOGLOBULIN HEAVY CHAINS) and two light chains (IMMUNOGLOBULIN LIGHT CHAINS) with additional ancillary polypeptide chains depending on their isoforms. The variety of isoforms include monomeric or polymeric forms, and transmembrane forms (B-CELL ANTIGEN RECEPTORS) or secreted forms (ANTIBODIES). They are divided by the amino acid sequence of their heavy chains into five classes (IMMUNOGLOBULIN A; IMMUNOGLOBULIN D; IMMUNOGLOBULIN E; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M) and various subclasses. Globulins, Immune,Immune Globulin,Immune Globulins,Immunoglobulin,Globulin, Immune
D008297 Male Males
D001855 Bone Marrow Diseases Diseases involving the BONE MARROW. Bone Marrow Disease,Disease, Bone Marrow,Diseases, Bone Marrow,Marrow Disease, Bone,Marrow Diseases, Bone
D002051 Burkitt Lymphoma A form of undifferentiated malignant LYMPHOMA usually found in central Africa, but also reported in other parts of the world. It is commonly manifested as a large osteolytic lesion in the jaw or as an abdominal mass. B-cell antigens are expressed on the immature cells that make up the tumor in virtually all cases of Burkitt lymphoma. The Epstein-Barr virus (HERPESVIRUS 4, HUMAN) has been isolated from Burkitt lymphoma cases in Africa and it is implicated as the causative agent in these cases; however, most non-African cases are EBV-negative. African Lymphoma,Burkitt Cell Leukemia,Burkitt Tumor,Lymphoma, Burkitt,Burkitt Leukemia,Burkitt's Leukemia,Burkitt's Lymphoma,Burkitt's Tumor,Leukemia, Lymphoblastic, Burkitt-Type,Leukemia, Lymphocytic, L3,Lymphocytic Leukemia, L3,Burkitts Leukemia,Burkitts Lymphoma,Burkitts Tumor,L3 Lymphocytic Leukemia,L3 Lymphocytic Leukemias,Leukemia, Burkitt,Leukemia, Burkitt Cell,Leukemia, Burkitt's,Leukemia, L3 Lymphocytic,Lymphoma, African,Lymphoma, Burkitt's,Tumor, Burkitt,Tumor, Burkitt's
D002648 Child A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL. Children
D002675 Child, Preschool A child between the ages of 2 and 5. Children, Preschool,Preschool Child,Preschool Children
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000293 Adolescent A person 13 to 18 years of age. Adolescence,Youth,Adolescents,Adolescents, Female,Adolescents, Male,Teenagers,Teens,Adolescent, Female,Adolescent, Male,Female Adolescent,Female Adolescents,Male Adolescent,Male Adolescents,Teen,Teenager,Youths
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults

Related Publications

R D Brunning, and R W McKenna, and C D Bloomfield, and P Coccia, and K J Gajl-Peczalska
January 1988, Leukemia research,
R D Brunning, and R W McKenna, and C D Bloomfield, and P Coccia, and K J Gajl-Peczalska
March 1972, British journal of haematology,
R D Brunning, and R W McKenna, and C D Bloomfield, and P Coccia, and K J Gajl-Peczalska
October 1968, British journal of haematology,
R D Brunning, and R W McKenna, and C D Bloomfield, and P Coccia, and K J Gajl-Peczalska
January 1973, American journal of diseases of children (1960),
R D Brunning, and R W McKenna, and C D Bloomfield, and P Coccia, and K J Gajl-Peczalska
October 1987, Minerva pediatrica,
R D Brunning, and R W McKenna, and C D Bloomfield, and P Coccia, and K J Gajl-Peczalska
January 1980, Leukemia research,
R D Brunning, and R W McKenna, and C D Bloomfield, and P Coccia, and K J Gajl-Peczalska
March 2015, Hematology/oncology and stem cell therapy,
R D Brunning, and R W McKenna, and C D Bloomfield, and P Coccia, and K J Gajl-Peczalska
February 1988, [Rinsho ketsueki] The Japanese journal of clinical hematology,
R D Brunning, and R W McKenna, and C D Bloomfield, and P Coccia, and K J Gajl-Peczalska
January 1990, Presse medicale (Paris, France : 1983),
R D Brunning, and R W McKenna, and C D Bloomfield, and P Coccia, and K J Gajl-Peczalska
January 1985, [Rinsho ketsueki] The Japanese journal of clinical hematology,
Copied contents to your clipboard!